The Southern African Journal of Infectious Diseases (SAJID), formerly called the Southern African Journal of Epidemiology and Infection (SAJEI), first appeared in 1985 as a joint publication of the Infectious Diseases Society of Southern Africa (IDSSA), the Sexually Transmitted Diseases Society of Southern Africa (STDSSA) and the Epidemiology Society of Southern Africa, the latter having subsequently been succeeded by the Public Health Association of South Africa (PHASA). Presently SAJID is published under the auspices of the Federation of Infectious Diseases Societies of South Africa which is an umbrella organisation incorporating IDSSA, STDSSA as well as the Infection Control Society of South Africa (ICASA), the National Antibiotic Study Forum (NASF) of South Africa, and the South African Society of Travel Medicine (SASTM).

Publications of SAJID centre round aspects of epidemiology and infection, particularly those of importance to the societies of FIDSSA. Topics around infection include clinical and epidemiological aspects of communicable diseases, laboratory diagnosis of infections, characterisation of infective agents by molecular techniques and the study of transmission patterns of pathogens in institutional and community settings. Other infection related studies cover surveillance of vaccine-controllable and other infectious diseases, drug susceptibility patterns of hospital-acquired and community-acquired pathogens and infection control strategies for the southern Africa region. SAJID also promotes greater collaboration between clinically oriented and laboratory-based divisions within the FIDSSA societies, and the establishment of quality assurance programmes and other measures to enhance and maintain standards of diagnostic and public health microbiology.

Scientific papers in the SAJID aim to advance the understanding of all aspects of epidemiology, public health, clinical microbiology and infection. The journal strives to promote research and exchange of information on specific areas of infectious diseases, medical microbiology and virology, covering fields of interest of the societies of FIDSSA and PHASA. Manuscripts describing research performed at southern African institutions and in southern African settings enjoy a high priority, as do health matters covering Africa and the developing world, as well as global issues such as malaria and other tropical diseases, tuberculosis, sexually transmitted infections and HIV/AIDS. The scope of interest of SAJID is wide but the journal aims to maintain and improve the standard of its publications.

Novartis urges patients to play a role in safer medical treatment

NOVARTIS URGES PATIENTS TO PLAY A ROLE IN SAFER MEDICAL TREATMENT Marking World Patient Safety Day, Novartis calls on patients be proactive about communication and adverse event reporting Novartis South Africa has urged South Africans to become more involved in...

Award-winning DOC-U-MENTALLY film now available on DVD

AWARD-WINNING DOC-U-MENTALLY FILM NOW AVAILABLE ON DVD Doc-U-Mentally – an award-winning film about the extreme pressures junior doctors face in South Africa is now available on DVD for R200. The documentary that was produced and directed by Francois Wahl, follows the...

EthiQal 1st Birthday

A new take on medical professional indemnity (PI) protection for doctors is turning the traditional, controversial indemnity insurance model on its head.

HIV prevention possible for those at high risk: men who have sex with men and transgender people

Right to Care, with the support of the Global Fund to Fight AIDS, TB and Malaria is rolling out Pre-Exposure Prophylaxis (PrEP) at three sites in Gauteng and one in the Western Cape, targeting those at high risk for HIV exposure particularly men who have sex with men and transgender people.

Eye strain the new affliction of the digital generation

While digital device usage is soaring, global awareness of digital eye strain is low, according to a new international survey carried out by Novartis among 6,000 people.